Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPregnancy after breast cancer: The importance of active counselling and planning
The Breast, 11/10/09
Rippy EE et al. – Pregnancy after breast cancer does not confer a poor prognosis. A higher rate of pregnancy than expected was found after treatment, possibly due to newer treatments including fertility preservation and also possibly due to the active counselling programme in this unit. Patients should have active counselling about fertility when planning treatment and fertility conservation can then be incorporated into a treatment plan.
Methods- 304 women 45 years and younger at time of diagnosis of breast cancer identified from 1 breast unit from 1997 to 2006
- Questionnaire sent to all patients asking about pregnancy, counselling and fertility issues
- Of 304 women, 248 still alive and not lost to follow up
- Questionnaire response rate 66% and average follow up was 60 mos
- By questionnaire response, 39 women had wanted children before diagnosis, and 24 still wanted them post treatment, giving successful pregnancy rate of 75%
- 18 patients have become pregnant, 4 with more than 1 pregnancy
- 107 patients specifically counselled about fertility prior to breast cancer treatment
- Mortality due to breast cancer 10% in non-pregnant patients and 6% in patients who became pregnant after breast cancer
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Bevacizumab and breast cancer: current therapeutic progress and future perspectives
Expert Review of Anticancer Therapy, 12/04/09
Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
Cancer Treatment Reviews, 12/04/09
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
Cancer Treatment Reviews, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor